MARKET

MCK

MCK

McKesson
NYSE

Real-time Quotes | Nasdaq Last Sale

336.44
+2.96
+0.89%
After Hours: 336.42 -0.02 -0.01% 16:13 05/26 EDT
OPEN
332.80
PREV CLOSE
333.48
HIGH
338.83
LOW
329.19
VOLUME
1.18M
TURNOVER
0
52 WEEK HIGH
339.94
52 WEEK LOW
183.30
MARKET CAP
48.91B
P/E (TTM)
47.01
1D
5D
1M
3M
1Y
5Y
Insider Sell: McKesson
MT Newswires · 12h ago
Fortune 500 List Includes Cryptocurrency Company For The First Time; 30 Return After Missing 2021
Fortune released its annual Fortune 500 list, ranking the largest companies in America by revenue. The list included a cryptocurrency company for the first time and saw several newcomers from the previous year.
Benzinga · 1d ago
Top Healthcare Stocks for June 2022
These are the healthcare stocks with the best value, fastest growth, and most momentum for June 2022.
Investopedia · 2d ago
UBS Adjusts McKesson Price Target to $380 From $303, Maintains Buy Rating
MT Newswires · 05/19 11:40
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and selling.
Benzinga · 05/17 17:25
Glenview Capital added Valvoline, exited Amgen, expanded position in US Foods, narrowed stake in Bausch Health
Larry Robbins and Mark Horowitz owned fund, Glenview Capital in its recent 13F filing disclosed newly acquired stakes in Valvoline (VVV) with 1.7M shares, Berkeley Lights (BLI) with 1.19M shares,
Seekingalpha · 05/17 14:41
Citigroup, Paramount Global stocks jump after Berkshire discloses new stakes
Citigroup (NYSE:C) stock is climbing 6.7% and Paramount Global (NASDAQ:PARA) is surging 9.9% in Tuesday morning trading after Warren Buffett's Berkshire Hathaway (NYSE:BRK.B) (NYSE:BRK.A) disclosed taking new investments in the companies during
Seekingalpha · 05/17 14:40
McKesson Brings in the Big Money
McKesson Corporation (MCK) stock has soared this year, rising 32.0% so far.
FX Empire · 05/17 11:09
More
No Data
Learn about the latest financial forecast of MCK. Analyze the recent business situations of McKesson through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

23.53%Strong Buy
52.94%Buy
23.53%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MCK stock price target is 360.54 with a high estimate of 395.00 and a low estimate of 320.00.
High395.00
Average360.54
Low320.00
Current 336.44
EPS
Actual
Estimate
1.543.084.616.15
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Institutional Holdings
Institutions: 1.51K
Institutional Holdings: 151.38M
% Owned: 104.13%
Shares Outstanding: 145.37M
TypeInstitutionsShares
Increased
343
7.76M
New
146
4.73M
Decreased
413
10.43M
Sold Out
95
1.27M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
+0.98%
Food & Drug Retailing
+2.19%
Key Executives
Non-Executive Chairman/Independent Director
Edward Mueller
Chief Executive Officer/Director
Brian Tyler
Chief Financial Officer/Executive Vice President
Britt Vitalone
Chief Human Resource Officer/Executive Vice President
Tracy Faber
Executive Vice President/Chief Technology Officer/Chief Information Officer
Nancy Flores
Executive Vice President/General Counsel
Lori Schechter
Executive Vice President
Tom Rodgers
Senior Vice President/Chief Accounting Officer/Controller
Napoleon Rutledge
Senior Vice President
Kevin Emerson
Director
James Hinton
Director
Kathleen Wilson - Thompson
Independent Director
Richard Carmona
Independent Director
Dominic Caruso
Independent Director
W. Roy Dunbar
Independent Director
Donald Knauss
Independent Director
Brad Lerman
Independent Director
Linda Mantia
Independent Director
Maria Martinez
Independent Director
Susan Salka
No Data
No Data
About MCK
McKesson Corporation is focused distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.

Webull offers kinds of McKesson Corporation stock information, including NYSE:MCK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MCK stock methods without spending real money on the virtual paper trading platform.